Pharmaceutical Intermediate Repaglinide CAS135062-02-1 Repaglinide Powder Material Repaglinide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung-Repaglinide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Repaglinide
• Name: Repaglinide Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical ;Anti Diabetic
• Specific: COA
• Test Method: HPLC UV
• Shelf Life: 2 Years
• CAS No.: 135062-02-1
• Mf: C27h36n2o4
• MW: 452.58600
• Density: 1.137g/cm3
• Melting Point: 129-130.2°c
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 5000kg/Month

Product Description

Pharmaceutical Intermediate Repaglinide CAS135062-02-1 Repaglinide powder Material Repaglinide

Product Description

Product Details

Product name	Repaglinide
Cas number	135062-02-1
Appearance	White powder
MF	C27H36N2O4
MW	452.58600

Repaglinide, a type of medicines for treating diabetes, is insulinotropic agent which belongs to the non-sulfonylurea. It was developed by Boehringer Ingelheim from Germany, and won approval by FDA from the United States in December 1997. In 1998, it was successively listed in the United States and European countries, with commodity name as NovoNorm. Mainly used in the clinical treatment of type diabetes (non-insulin-dependent) patients whose hyperglycemia can't be effectively controlled via diet, weight loss and exercise.

Application&Function

Repaglinide lowers blood glucose by stimulating the release of insulin from the pancreas.
Repaglinide achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. This depolarizes the beta cells, opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion.

Specification